India has rejected allegations in a US report about the country being a chief source of counterfeit medicines and said it is an attack on low cost generic drugs — crucial to make healthcare affordable. A report by United States Trade Representative (USTR) had earlier slammed India and China as leading sources of counterfeit medicines distributed globally.
Read full Post
Sunday, April 28, 2019
India slams US for 'attack on generic drugs'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment